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Amyloidosis is characterised by the extracellular deposition of abnormal protein
fibrils. Recent advances in the study of amyloidosis have been based on the
chemical analysis of these protein fibrils.1,2 This has also led to a more rational
classification of the condition (Fig 1). Further discussion of localised forms of






'PLASMA CELL DYSCRASIA - AL
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Fig 1. Classification of amyloidosis
Systemic amyloidosis may be either inherited or acquired. The neuropathic
forms, which show an autosomal dominant inheritance, predominantly affect
peripheral nerves, but may involve also the heart, kidneys and other tissues. The
protein fibrils are derived from circulating prealbumin, which has an inherited
abnormality in the amino acid sequence in some kindreds.3 The most studied
form of inherited non -neuropathic amyloidosis is familial Mediterranean fever
(FMF). This autosomal recessive disorder is confined to populations originating
on the southern and eastern coasts of the Mediterranean Sea. It is characterised
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by recurrent acute inflammatory attacks of various types (abdominal pain,
polyserositis, arthritis, skin rashes) and the gradual deposition of amyloid protein,
most notably in the kidneys. The amyloid fibrils in FMF are derived
from a circulating acute phase reactant known as serum amyloid A (SAA)
protein. Serum amyloid A is also the major precursor protein of acquired reactive
systemic amyloidosis (AA amyloid). This may occur as a complication of chronic
inflammatory diseases such as rheumatoid arthritis or chronic infection, and was
previously classified as secondary amyloidosis.
The other main type of systemic amyloidosis is AL amyloid, which is derived
largely from the variable regions of immunoglobulin light chains, secreted by a
clone of plasma cells. This clone may give rise to overt myeloma with features
such as lytic lesions in bone but may also present solely as amyloidosis. Such
cases were previously classified as primary amyloidosis.
Amyloidosis is an uncommon condition, with a wide variety of clinical present-
ations, and for this reason the diagnosis may be overlooked. Three cases
presented to a general medical ward within a three-month period. We describe
these cases to illustrate the diverse features of the disorder.
CASE I
A 62-year-old lady presented with swollen salivary glands and mild cardiac
failure. She also complained of dvsrhacia. loss of hair. eDisodes of sDontaneous
bruising around the eyes, and aching
muscles. She had been well until
one year previously when she had
complained of aching leg and back
muscles on exertion and had had an
operation for spinal stenosis, without
improvement in her symptoms. On
examination, the submandibular
glands were enlarged and had a firm
rubbery consistency, the tongue was
grossly enlarged and showed indent-
ations made by her teeth (Fig 2).
The skeletal muscles were enlarged
and indurated to give an incongrous
brawny appearance (American foot-
baller or shoulder Dad sian). Biopsy
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of deltoid muscle showed extensive infiltration of the interstitium with amyloid
which was permanganate resistant. Biopsy of the rectum contained mucosa only
and did not contain any amyloid. A type G -lambda paraprotein was present in the
serum (6g/1) and urine (0.7g/1). Bone marrow trephine revealed a moderate
increase in plasma cells (15%). No lytic lesions were present on skeletal survey
and other investigations revealed normal haemoglobin, urea and serum albumin
concentrations and ESR of 25 mm/hr. An electrocardiogram (ECG) showed low
voltage complexes.
The cardiac failure was easily controlled by diuretics. A course of melphalan and
prednisolone was given but there was no reduction in the serum paraprotein
concentration. The most disabling symptoms were dysphagia due to progressive
enlargement of the tongue and generalised muscular weakness. The patient died
nine months after diagnosis from a respiratory arrest.
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CASE 2
A 62-year-old man presented with oedema due to nephrotic syndrome and
cardiac failure. Hehad been previouslywell. Urinary protein loss was6g/24 hours
(normal less than 0.15g) and serum albumin was reduced to 16g/litre (normal
35 - 50). However, renal function was preserved as indicated by a normal urea
concentration 5.1 mmol/l (3- 6). A type G -lambda paraprotein was present in
the serum (10g/1) and urine (concentration not measured). The kidneys showed
increased echogenicity on ultrasound examination. ECG showed low voltage
complexes. The cardiac failure and oedema proved resistant to intensive treat -
ment with diuretics and albumin infusions. Melphalan and prednisolone therapy
was commenced, but the patient died from a bleeding duodenal ulcer five weeks
after presentation. At autopsy, the heart, kidneys, spleen and liver were heavily
infiltrated with amyloid which was permanganate resistant. The blood vessels in
the base of the duodenal ulcer were also infiltrated with amyloid. There were large
numbers of plasma cells in the bone marrow (proportion not estimated).
CASE 3
A 58-year-old man was referred for investigation of diarrhoea. Two years
previously he had developed cardiac failure and was diagnosed as having amyloid
heart disease by endomyocardial biopsy at the Regional Medical Cardiology
Centre, Royal Victoria Hospital, Belfast. Prior to this, he had been healthy, with no
history of chronic inflammatory disease, ischaemic heart disease or hypertension.
He was of Anglo -Irish descent with no family history of amyloidosis. On his initial
presentation he underwent extensive cardiac investigation. ECG showed sinus
rhythm, some reduction in voltage of the limb lead complexes and T wave
inversion in leads, 11, 111, AVF, V1 - V4. Echocardiographic appearances were
consistent with a cardiac infiltration. A pyrophosphate radioisotope scan
demonstrated diffuse intense uptake of the isotope by both ventricles which is a
characteristic finding in cardiac amyloidosis.4 Amyloid was demonstrated in the
endomycardial biopsy stained with Congo red, and amyloid fibrils were also
demonstrated by electron microscopy. At this time ESR was 8 mm/hr and there
was no detectable paraprotein in serum or urine. A radiological skeletal survey
and bone marrow examination were not performed. His cardiac failure was
treated with Digoxin and diuretics and a course of Cyclophosphamide was given.
However, over a two year period he became progressively disabled by diarrhoea,
postural dizziness and muscular weakness. On examination his muscles were
wasted and weak. All tendon reflexes were absent, and sensory testing of the
extremities caused unpleasant dysasthesia. Blood pressure was 110/70 mmHg
supine and 55/40 mmHg erect.
A barium enema was normal, small bowel X -ray series showed coarsening of the
mucosal folds and was notable for the rapid transit time from mouth to caecum of
15 minutes. Nerve condition velocities were significantly slowed (median nerve
41 m/sec, posterior tibial nerve 36 m/sec). Heart rate on ECG monitoring did not
alterwith posture, respiration orvalsalva manoeuvre consistent with an autonomic
neuropathy.5 Rectal biopsy showed amyloid in the submucosa and pre-treatment
of the tissue sections with permanganate gave equivocal results. Haemoglobin,
ESR and a biochemical screen for malabsorption were normal. Serum urea was
3.9 mmol/l (3 - 6) and protein loss in the urine was less than 0.1 gm/24 hours.
Electrophoresis of serum and concentrated urine (x250) was repeated and
combined with immunofixation techniques but still failed to demonstrate a
paraprotein.
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The cause of the diarrhoea was diagnosed as autonomic neuropathy due to
amyloidosis. The postural hypotension has been improved by support stockings.
The peripheral neuropathy persists and has progressed to the extent that the
patient now requires a frame to aid walking. His cardiac failure remains well
controlled by Digoxin and modest doses of diuretics.
DISCUSSION
Case 1 illustrates three clinical signs which are virtually pathognomonic of AL
amyloidosis. These are the enlarged, indurated tongue, the shoulder pad or
American footballer sign and spontaneous periorbital purpura. The purpura
typically occurs after proctoscopy for a rectal biopsy and can be abbreviated to
the more memorable PPPP (post proctoscopic periorbital purpura).6
Cases 1 and 2 are undoubtedly examples of AL amyloidosis since a circulating
paraprotein was detected and there was an increased proportion of plasma cells
in the bone marrow. In Case 3 a paraprotein was not detected which makes the
classification of the amyloid type less certain. The detection of a paraprotein is
not essential for the diagnosis of AL amyloidosis and cannot be detected in the
serum in 32% of cases and in the urine in 28% of cases.6 This patient presented
with cardiac and neural involvement which are both common presentations ofAL
amyloidosis.7 The normal urinary excretion of protein is unusual but can occur in
10% of cases.6 Acquired reactive AA amyloidosis is excluded by the absence of
underlying inflammatory disease. However, it is not possible to excludea sporadic
case of inherited amyloidosis, despite the lack offamily history and the late age of
onset (58 years).8
Histochemical analysis using a potassium permanganate technique 9 was
unhelpful in this case. This technique is useful for identifying AA amyloid but
does not distinguish ALamyloid from inherited amyloid consisting ofprealbumin.
Immunocytochemistry offers theprospectofaspecific staining method. However,
it has proved difficult to raise suitable antibodies to AL amyloid proteins because
they are derived from the variable rather than the constant regions of the
immunoglobulin light chains. Recently, Dalakas and co -workers have reported a
series of 15 patients with amyloid polyneuropathy stained using antibodies to
immunoglobulin light chains and prealbumin.10 These patients had no family
history of amyloidosis and no evidence of a plasma cell dyscrasia. In 12 ofthe 15
cases the amyloid protein was AL and in 3 it was prealbumin. We conclude that
Case 3 is probably an example of AL amyloidosis but the classification will not
be certain until these immunocytochemical techniques become more widely
available.
In Cases 1 and 2 the immunoglobulin light chain belongs to the lambda (X) class.
This is consistent with previous observations that X chains are found twice as
frequently as kappa (K) chains in AL amyloidosis, which is in contrast with
myeloma not complicated by amyloidosis, in which K chains are twice as
common as X .6 It is not clear why X chains should be more 'amyloidogenic' than
K chains.
A histological diagnosis is essential to confirm amyloidosis. Tissue sections which
contain amyloid exhibit apple.-green birefringence when stained with Congo red
and examined under polarised light. Amyloid fibrils also have a characteristic
appearance when examined by electron microscopy. The best site for initial
biopsy is the rectum, which is positive in 80% of cases provided that submucosal
tissue is obtained. The rectal biopsy in Case 1 was not deep enough to include
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submucosa which is the most likely reason for the failure to detect amyloid. It
may be necessary to biopsy other tissues if rectal biopsy is negative, although
there is the risk of bleeding due to vessel wall infiltration or factor X deficiency
which is a rare feature of AL amyloidosis.1
The treatmentofAL amyloidosisis unsatisfactory. The most logical approach isto
suppress light chain production using regimes such as melphalan and prednisone
or cyclophosphamide which are of use for multiple myeloma. A prospective trial
of melphalan and prednisoneversus placeboshowed thatthenephrotic syndrome
improved in a few patients but survival was not significantly changed.12 Colchicine
is effective in preventing amyloidosis in familial Mediterranean fever.13 However,
the survival of patients with AL amyloidosis is marginally worse when treated with
colchicine as compared to melphalan and prednisone.14
Melphalan and prednisolone were given in Cases 1 and 2 and cyclophosphamide
in Case 3. In the first case, amyloidosis progressed despite treatment. In Case 2
the patient died before any response to treatment could have been expected. In
Case 3 the patient has remained relatively well following the course of
cyclophosphamide, but it is not possible to know whether this can be attributed to
the drug.
We thank Dr Claire Hill for advice on the histopathology of amyloidosis.
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